Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bing-Hua Jiang

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
Current Cancer Drug Targets|April 30, 2013
PI3K/AKT and mTOR/p70S6K1 signaling pathways in human cancerBing-Hua Jiang
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|November 19, 2002
Antioxidant properties of apple juice and its protection against Cr(VI)-induced cellular injuryDavid Shi, Bing-Hua Jiang
Current Cancer Drug Targets|January 10, 2013
Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancerFaton Agani, Bing-Hua Jiang
Current Pharmacology Reports|June 11, 2016
Interplay between Reactive oxygen Species and MicroRNAs in CancerJun He, Bing-Hua Jiang
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 29, 2008
Role of mTOR in anticancer drug resistance: perspectives for improved drug treatmentBing-Hua Jiang, Ling-Zhi Liu
Current Cancer Drug Targets|February 22, 2008
AKT signaling in regulating angiogenesisBing-Hua Jiang, Ling-Zhi Liu
Advances in Cancer Research|July 15, 2009
PI3K/PTEN signaling in angiogenesis and tumorigenesisBing-Hua Jiang, Ling-Zhi Liu
Current Cancer Drug Targets|January 10, 2013
Roles of EGFR, PI3K, AKT, and mTOR in heavy metal-induced cancerRichard L Carpenter, Bing-Hua Jiang
Biochimica Et Biophysica Acta|October 30, 2007
PI3K/PTEN signaling in tumorigenesis and angiogenesisBing-Hua Jiang, Ling-Zhi Liu
Bioinformatics (Oxford, England)|April 24, 2012
Probabilistic suffix array: efficient modeling and prediction of protein familiesJie Lin, Donald Adjeroh, Bing-Hua Jiang
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
Current Cancer Drug Targets|April 30, 2013
PI3K/AKT and mTOR/p70S6K1 signaling pathways in human cancerBing-Hua Jiang
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|November 19, 2002
Antioxidant properties of apple juice and its protection against Cr(VI)-induced cellular injuryDavid Shi, Bing-Hua Jiang
Current Cancer Drug Targets|January 10, 2013
Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancerFaton Agani, Bing-Hua Jiang
Current Pharmacology Reports|June 11, 2016
Interplay between Reactive oxygen Species and MicroRNAs in CancerJun He, Bing-Hua Jiang
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 29, 2008
Role of mTOR in anticancer drug resistance: perspectives for improved drug treatmentBing-Hua Jiang, Ling-Zhi Liu
Current Cancer Drug Targets|February 22, 2008
AKT signaling in regulating angiogenesisBing-Hua Jiang, Ling-Zhi Liu
Advances in Cancer Research|July 15, 2009
PI3K/PTEN signaling in angiogenesis and tumorigenesisBing-Hua Jiang, Ling-Zhi Liu
Current Cancer Drug Targets|January 10, 2013
Roles of EGFR, PI3K, AKT, and mTOR in heavy metal-induced cancerRichard L Carpenter, Bing-Hua Jiang
Biochimica Et Biophysica Acta|October 30, 2007
PI3K/PTEN signaling in tumorigenesis and angiogenesisBing-Hua Jiang, Ling-Zhi Liu
Bioinformatics (Oxford, England)|April 24, 2012
Probabilistic suffix array: efficient modeling and prediction of protein familiesJie Lin, Donald Adjeroh, Bing-Hua Jiang
Pageof 19